SnapShot: Lysosomal Storage Diseases
- PMID: 32032518
- PMCID: PMC8411567
- DOI: 10.1016/j.cell.2020.01.017
SnapShot: Lysosomal Storage Diseases
Abstract
Lysosomal storage diseases (LSDs) represent a group of monogenic inherited metabolic disorders characterized by the progressive accumulation of undegraded substrates inside lysosomes, resulting in aberrant lysosomal activity and homeostasis. This SnapShot summarizes the intracellular localization and function of proteins implicated in LSDs. Common aspects of LSD pathogenesis and the major current therapeutic approaches are noted. To view this SnapShot, open or download the PDF.
Copyright © 2020 Elsevier Inc. All rights reserved.
References
-
- Luzio JP, Pryor PR, and Bright NA (2007). Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol 8, 622–632. - PubMed
-
- Marques ARA, and Saftig P (2019). Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases. J. Cell Sci 132, jcs221739. - PubMed
-
- Parenti G, Andria G, and Ballabio A (2015). Lysosomal storage diseases: from pathophysiology to therapy. Annu. Rev. Med 66, 471–486. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
